All Articles
Updated National Comprehensive Cancer Network (NCCN) guidelines now recommend zanubrutinib as alternative first- and second-line therapy for some patients. Read More ›
Cannabis compounds such as cannabidiol have shown cancer-fighting activity in the lab. What should patients know? Read More ›
April is National Minority Health Month and National Minority Cancer Awareness Month, a time to reflect and shine a light on the disparities that minority populations face in cancer care. Read More ›
A new model of the symptoms and impacts faced by patients may lead to better clinical tools for understanding the patient experience. Read More ›
Patients who are in a period of active observation should feel comfortable sharing anything that seems abnormal with their healthcare provider. Read More ›
A greater number of comorbidities alone may not be sufficient to predict patient survival; age and stage at diagnosis must be considered as well. Read More ›
The first phase 3 trial comparing these drugs shows that acalabrutinib has similar efficacy as ibrutinib with a lower risk of a worrisome side effect. Read More ›
By Rosie Kelly
Social workers serve as “dot connectors” to help patients with cancer overcome barriers. Today, on World Social Work Day, CONQUER magazine celebrates social workers everywhere. Read More ›
As we reflect on 1 year of living in a pandemic, here’s what we’ve learned about COVID-19, cancer, and the road ahead. Read More ›